Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (411-420 of 561) with videos related to

Pageof 57
Sort By:
World Journal of Urology|August 12, 2024
Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancerAlexandre Guigui, Giuseppe Basile, Fabio Zattoni, et al.
European Urology Focus|June 15, 2021
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-AnalysisEkaterina Laukhtina, Pawel Rajwa, Keiichiro Mori, et al.
International Urology and Nephrology|May 7, 2025
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
The Lancet. Oncology|March 2, 2026
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 studyAndrea Necchi, Brigida A Maiorano, Joep J de Jong, et al.
Clinical Genitourinary Cancer|November 7, 2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
Clinical Genitourinary Cancer|July 7, 2024
Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy CandidatesMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
World Journal of Urology|January 19, 2026
Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2023
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysisKeiichiro Mori, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
Annals of Surgical Oncology|January 13, 2026
ASO Visual Abstract: The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility CriteriaMattia Longoni, Quynh Chi Le, Fabian Falkenbach, et al.
Journal of Surgical Oncology|May 1, 2023
Age represents the main driver of surgical decision making in patients candidate to radical cystectomyPaolo Dell'Oglio, Stefano Tappero, Andrea Panunzio, et al.
Pageof 57

Showing results (411-420 of 561) with videos related to

Sort By:
Pageof 57
World Journal of Urology|August 12, 2024
Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancerAlexandre Guigui, Giuseppe Basile, Fabio Zattoni, et al.
European Urology Focus|June 15, 2021
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-AnalysisEkaterina Laukhtina, Pawel Rajwa, Keiichiro Mori, et al.
International Urology and Nephrology|May 7, 2025
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
The Lancet. Oncology|March 2, 2026
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 studyAndrea Necchi, Brigida A Maiorano, Joep J de Jong, et al.
Clinical Genitourinary Cancer|November 7, 2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
Clinical Genitourinary Cancer|July 7, 2024
Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy CandidatesMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
World Journal of Urology|January 19, 2026
Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2023
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysisKeiichiro Mori, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
Annals of Surgical Oncology|January 13, 2026
ASO Visual Abstract: The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility CriteriaMattia Longoni, Quynh Chi Le, Fabian Falkenbach, et al.
Journal of Surgical Oncology|May 1, 2023
Age represents the main driver of surgical decision making in patients candidate to radical cystectomyPaolo Dell'Oglio, Stefano Tappero, Andrea Panunzio, et al.
Pageof 57